Evaluation of parametrial spread in endometrial carcinoma

Obstetrics and Gynecology

Volumn 116, Issue 5, 2010, Pages 1027-1034

  Watanabe, Yoh ^a   Satou, Takao ^a   Nakai, Hidekatsu ^a   Etoh, Tomomaro ^a   Dote, Kensaku ^a   Fujinami, Nahoko ^a   Hoshiai, Hiroshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; BLOOD VESSEL INVASION; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONNECTIVE TISSUE TUMOR; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPHOVASCULAR SPACE INVASION; MAJOR CLINICAL STUDY; METASTASIS; MUCINOUS CARCINOMA; MULTIMODALITY CANCER THERAPY; MYOMETRIUM; OVARY METASTASIS; PARAAORTIC METASTASIS; PELVIS METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; ENDOMETRIAL NEOPLASMS; HYSTERECTOMY; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; SECONDARY; TREATMENT OUTCOME; TUMOR INVASION; UTERUS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; TREATMENT OUTCOME; UTERUS;

EID: 78049335265     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181f80a49     Document Type: Article

References (33)

1. Clinical Practice Guidelines in Oncology. National Comprehensive Cancer Network. http//www.nccn.org/professionals/physician-gls/PDF/uterine.pdf. Retrieved June, 09 2010.
2. Endometrial cancer treatment guidelines 2006 [Japanese]. Japan Society of Gynecologic Oncology. Tokyo (Japan): Kane-hara-Syuppan2006.
3. Watanabe Y, Aoki D, Kitagawa R, Takeuchi S, Sagae S, Sakuragi N, et al. Status of surgical treatment procedures for endometrial cancer in Japan: results of a Japanese Gynecologic Oncology Group survey. Gynecol Oncol 2007;105:325-8.
4. Yura Y, Tauchi K, Koshiyama M, Konishi I, Yura S, Mori T, et al. Parametrial involvement in endometrial carcinomas: Its incidence and correlation with other histological parameters. Gynecol Oncol 1996;63:114-9.
5. Tamussino KF, Reich O, Gucer F, Moser F, Zivkovic F, Lang PF, et al. Parametrial spread in patients with endometrial carcinoma undergoing radical hysterectomy. Int J Gynecol Cancer 2000;10:313-7.
6. Sato R, Jobo T, Kuramoto H. Parametrial spread is a prognostic factor in endometrial carcinoma. Eur J Gynecol Oncol 2003;24:241-5.
7. Lee TS, Kim JW, Kim DY, Kim YT, Lee KH, Kim BG, et al. Necessity of radical hysterectomy for endometrial cancer patients with cervical invasion. J Korean Med Sci 2010;25: 552-6.
8. Malur S, Possover M, Michels W, Schneider A. Laparoscopic-assisted vaginal versus abdominal surgery in patients with endometrial cancer\-a prospective randomized trial. Gynecol Oncol 2001;80:239-44.
9. Fram KM. Laparoscopically assisted vaginal hysterectomy versus abdominal hysterectomy in stage I endometrial cancer. Int J Gynecol Cancer 2002;12:57-61.
10. Palomba S, Falbo A, Mocciaro R, Russo T, Zullo F. Laparo-scopic treatment for endometrial cancer: a meta-analysis of randomized control trials (RCTs). Gynecol Oncol 2009;112: 415-21.
11. Zullo F, Palomba S, Falbo A, Russo T, Mocciaro R, Tartaglia E, et al. Laparoscopic surgery vs laparotomy for early stage endometrial cancer: long-term data of a randomized control trial. Am J Obstet Gynecol 2009;200:296.e1-9.
12. Sasaki H, Yoshida T, Noda K, Yachiku S, Minami K, Kaneko S. Urethral pressure profiles following radical hysterectomy. Obstet Gynecol 1982;59:101-4.
13. Noda K. Presevation of function and radicality in radical operation of cancer of the uterine cervix. Gan To Kagaku Ryoho 1988;15:1150-3.
14. Rutledge F. The role of radical hysterectomy in adenocarci-noma of the endometrium. Gynecol Oncol 1974;2:331-47.
15. Roberts DWT. Carcinoma of the body of the uterus at Chelsea Hospital for Women, 1943-1953. J Obstet Gynaecol Br Com-monw 1961;68:132-8.
16. Parsons L, Cesare F. Wertheim hysterectomy in the treatment of endometrial carcinoma. Surg Gynecol Obstet 1959;108: 582-90.
17. Lefevre H. Node dissection in cancer of the endometrium. Surg Gynecol Obstet 1956;102:649-56.
18. Boothby RA, Carlson JA, Neiman W, Rubin MM, Morgan MA, Schults D, et al. Treatment of stage II endometrial carcinoma. Gynecol Oncol 1989;33:204-8.
19. Boente MP, Yordan EL Jr, McIntosh DG, Grendys EC Jr, Orandi YA, Davies S, et al. Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol Oncol 1993;51:316-22.
20. Boente MP, Orandi YA, Yordan EL, Miller A, Graham JE, Kirshner C, et al. Recurrence patterns and complications in endometrial adenocarcinoma with cervical involvement. Ann Surg Oncol 1995;2:138-44.
21. Sartori E, Gadducci A, Landoni F, Lissoni A, Maggino T, Zola P, et al. Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. Int J Gynecol Cancer 2001;11:430-7.
22. Ayhan A, Taskiran C, Celik C, Yuce K. The long-term survival of women with surgical stage II endometrioid type endometrial cancer. Gynecol Oncol 2004;93:9-13.
23. Gadducci A, Cavazzana A, Cosio S, DI Cristofano C, Tana R, Fanucchi A, et al. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patient with stage I-II endometrioid-type endometrial cancer. Anticancer Res 2009; 29:1715-20.
24. Inoue Y, Obata K, Abe K, Ohmura G, Doh K, et al. The prognostic significance of vascular invasion by endometrial carcinoma. Cancer 1996;78:1447-51.
25. Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Gynecol Oncol 2005;96:651-7.
26. Briet JM, Hollema H, Reesink N, Aalders JG, Mourits MJ, ten Hoor KA, et al. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol 2005;96:799-804.
27. Gemer O, Arie AB, Levy T, Gdalevich M, Lorian M, Barak F, et al. Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: results of a multicenter study. Eur J Surg Oncol 2005;33:644-7.
28. Sartori E, Gadducci A, Landoni F, Lissoni A, Maggino T, Zola P, et al. Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. Int J Gynecol Cancer 2001;11:430-7.
29. Mariani A, Webb MJ, Keeney GL, Calori G, Podratz KC. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement. Gynecol Oncol 2001;83:72-80.
30. Cornelison TL, Trimble EL, Kosary CL. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994. Gynecol Oncol 1999;74:350-5.
31. Cohn DE, Woeste EM, Cacchio S, Zanagnolo VL, Havrilesky LJ, Mariani A, et al. Clinical and pathologic correlates in surgical stage II endometrial carcinoma. Obstet Gynecol 2007; 109:1062-7.
32. Pete I, Godeny M, Toth E, Rado J, Pete B, Pulay T. Prediction of cervical infiltration in Stage II endometrial cancer by different preoperative evaluation techniques (D&C, US, CT, MRI). Eur J Gynaecol Oncol 2003;24:517-22.
33. Creasman WT, DeGeest K, DiSaia PJ, Zaino RJ. Significance of true surgical pathologic staging: a Gynecologic Oncology Group Study. Am J Obstet Gynecol 1999;181:31-4.